US EditionPublished • loading... • Updated
GLP-1 Recombinant Analogs Advance as Targeted Therapies for Diabetes and Obesity
Summary by GeneOnline News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
GLP-1 Recombinant Analogs Advance as Targeted Therapies for Diabetes and Obesity
Peptide therapeutics, including GLP-1 receptor agonists […] The post GLP-1 Recombinant Analogs Advance as Targeted Therapies for Diabetes and Obesity first appeared on GeneOnline News. The post GLP-1 Recombinant Analogs Advance as Targeted Therapies for Diabetes and Obesity appeared first on GeneOnline News.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
